Christopher Stone

944 total citations
18 papers, 733 citations indexed

About

Christopher Stone is a scholar working on Infectious Diseases, Virology and Surgery. According to data from OpenAlex, Christopher Stone has authored 18 papers receiving a total of 733 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 10 papers in Virology and 4 papers in Surgery. Recurrent topics in Christopher Stone's work include HIV Research and Treatment (10 papers), HIV/AIDS drug development and treatment (10 papers) and HIV/AIDS Research and Interventions (7 papers). Christopher Stone is often cited by papers focused on HIV Research and Treatment (10 papers), HIV/AIDS drug development and treatment (10 papers) and HIV/AIDS Research and Interventions (7 papers). Christopher Stone collaborates with scholars based in United States, United Kingdom and France. Christopher Stone's co-authors include Margaret Tisdale, Mounir Ait‐Khaled, Philip Griffin, Christine Katlama, Schlomo Staszewski, Stuart Bloor, Isabel Nájera, Sharon D. Kemp, P. Richard Harrigan and Amy Cutrell and has published in prestigious journals such as Circulation, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Christopher Stone

17 papers receiving 696 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher Stone United States 10 672 550 147 108 55 18 733
José Valdez Madruga Brazil 7 775 1.2× 600 1.1× 181 1.2× 154 1.4× 47 0.9× 11 829
Kati Vandermeulen Belgium 12 651 1.0× 480 0.9× 133 0.9× 177 1.6× 45 0.8× 19 713
Anna Danise Italy 13 382 0.6× 289 0.5× 128 0.9× 104 1.0× 25 0.5× 24 504
Magda Opsomer Belgium 12 422 0.6× 293 0.5× 78 0.5× 123 1.1× 35 0.6× 29 517
Miguel Goicoechea United States 10 467 0.7× 282 0.5× 129 0.9× 183 1.7× 34 0.6× 24 572
Teresa García-Benayas Spain 13 395 0.6× 289 0.5× 85 0.6× 182 1.7× 25 0.5× 18 482
Victoria Wirtz United States 11 820 1.2× 591 1.1× 100 0.7× 359 3.3× 50 0.9× 21 904
Frank Tomaka United States 12 653 1.0× 446 0.8× 133 0.9× 161 1.5× 22 0.4× 24 713
Lucinda R. Gilde United States 3 573 0.9× 513 0.9× 57 0.4× 78 0.7× 137 2.5× 3 627
Naomi Givens United Kingdom 9 566 0.8× 399 0.7× 107 0.7× 200 1.9× 35 0.6× 17 609

Countries citing papers authored by Christopher Stone

Since Specialization
Citations

This map shows the geographic impact of Christopher Stone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Stone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Stone more than expected).

Fields of papers citing papers by Christopher Stone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Stone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Stone. The network helps show where Christopher Stone may publish in the future.

Co-authorship network of co-authors of Christopher Stone

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Stone. A scholar is included among the top collaborators of Christopher Stone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Stone. Christopher Stone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Stone, Christopher, et al.. (2024). Sodium-Glucose Cotransporter-2 Inhibition Normalizes Metabolic Derangements in the Ischemic Myocardium. Journal of Surgical Research. 303. 600–612. 1 indexed citations
2.
Stone, Christopher, et al.. (2024). Semaglutide Improves Myocardial Perfusion and Performance in a Large Animal Model of Coronary Artery Disease. Arteriosclerosis Thrombosis and Vascular Biology. 45(2). 285–297. 9 indexed citations
3.
Stone, Christopher, et al.. (2024). Dipeptidyl peptidase-4 inhibitor linagliptin improves fibrosis, apoptosis, and cardiac function in a large animal model of chronic myocardial ischemia. Journal of Pharmacology and Experimental Therapeutics. 392(2). 100532–100532. 1 indexed citations
4.
Sabe, Sharif A., et al.. (2024). Effects of diet-induced metabolic syndrome on cardiac function and angiogenesis in response to the sodium-glucose cotransporter-2 inhibitor canagliflozin. Journal of Thoracic and Cardiovascular Surgery. 168(5). e183–e199. 2 indexed citations
5.
Teixeira, Rayane Brinck, Christopher Stone, Cynthia Xu, et al.. (2024). Lab-grown, 3D extracellular matrix particles improve cardiac function and morphology in myocardial ischemia. American Journal of Physiology-Heart and Circulatory Physiology. 328(2). H221–H234. 1 indexed citations
6.
7.
Stone, Christopher, et al.. (2024). Protein Kinase C-β Inhibition and Survival Signaling after Simulated Cardioplegic-Ischemia/Reperfusion in Nondiabetic and Diabetic Human Coronary Arterial Endothelial Cells. Journal of the American College of Surgeons. 241(2). 118–135. 2 indexed citations
8.
Givens, Naomi, Christopher Stone, Philip Griffin, et al.. (2004). Effect of concurrent zidovudine use on the resistance pathway selected by abacavir‐containing regimens. HIV Medicine. 5(6). 394–399. 30 indexed citations
9.
Stone, Christopher, Mounir Ait‐Khaled, Charles Craig, Philip Griffin, & Margaret Tisdale. (2004). Human Immunodeficiency Virus Type 1 Reverse Transcriptase Mutation Selection during In Vitro Exposure to Tenofovir Alone or Combined with Abacavir or Lamivudine. Antimicrobial Agents and Chemotherapy. 48(4). 1413–1415. 32 indexed citations
10.
Lanier, E. Randall, Mounir Ait‐Khaled, Christopher Stone, et al.. (2004). Antiviral Efficacy of Abacavir in Antiretroviral Therapy-Experienced Adults Harbouring HIV-1 with Specific Patterns of Resistance to Nucleoside Reverse Transcriptase Inhibitors. Antiviral Therapy. 9(1). 37–45. 43 indexed citations
11.
12.
Ait‐Khaled, Mounir, Christopher Stone, Bonaventura Clotet, et al.. (2002). M184V is associated with a low incidence of thymidine analogue mutations and low phenotypic resistance to zidovudine and stavudine. AIDS. 16(12). 1686–1689. 41 indexed citations
13.
14.
Miller, Veronica, Mounir Ait‐Khaled, Christopher Stone, et al.. (2000). HIV-1 reverse transcriptase (RT) genotype and susceptibility to RT inhibitors during abacavir monotherapy and combination therapy. AIDS. 14(2). 163–171. 107 indexed citations
15.
Katlama, Christine, Bonaventura Clotet, Andreas Plettenberg, et al.. (2000). The role of abacavir (ABC, 1592) in antiretroviral therapy-experienced patients: results from a randomized, double-blind, trial. AIDS. 14(7). 781–789. 49 indexed citations
16.
Harrigan, P. Richard, Christopher Stone, Isabel Nájera, et al.. (2000). Resistance Profile of the Human Immunodeficiency Virus Type 1 Reverse Transcriptase Inhibitor Abacavir (1592U89) after Monotherapy and Combination Therapy. The Journal of Infectious Diseases. 181(3). 912–920. 127 indexed citations
17.
Moodley, Jagidesa, Dhayendre Moodley, Kubendran Pillay, et al.. (1998). Pharmacokinetics and Antiretroviral Activity of Lamivudine Alone or When Coadministered with Zidovudine in Human Immunodeficiency Virus Type 1–Infected Pregnant Women and Their Offspring. The Journal of Infectious Diseases. 178(5). 1327–1333. 150 indexed citations
18.
Stone, Christopher, D. Craig Allred, Bonnie Oliver, Stanley Cohen, & Roger S. Thrall. (1991). A comparison of foreign body and hypersensitivity granuloma formation in the mouse: Kinetic development, anergy, angiotensin converting enzyme levels, and response to captopril therapy. Clinical Immunology and Immunopathology. 58(1). 56–68. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by José Valdez Madruga Breakdown of academic impact, for papers by Kati Vandermeulen Breakdown of academic impact, for papers by Anna Danise Breakdown of academic impact, for papers by Magda Opsomer Breakdown of academic impact, for papers by Miguel Goicoechea Breakdown of academic impact, for papers by Teresa García-Benayas Breakdown of academic impact, for papers by Victoria Wirtz Breakdown of academic impact, for papers by Frank Tomaka Breakdown of academic impact, for papers by Lucinda R. Gilde Breakdown of academic impact, for papers by Naomi Givens
Rankless by CCL
2026